- Home
- ORRF vs BIOA Comparison
ORRF vs BIOA Comparison
Compare ORRF & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORRF | BIOA |
|---|---|---|
| Founded | 1919 | 2015 |
| Country | United States | United States |
| Employees | N/A | 64 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 734.3M | 856.3M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORRF | BIOA |
|---|---|---|
| Price | $34.28 | $20.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $42.00 | ★ $44.40 |
| AVG Volume (30 Days) | 140.7K | ★ 467.4K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.41% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.07 | N/A |
| Revenue | ★ $27,312,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.49 | $898.47 |
| P/E Ratio | $11.46 | ★ N/A |
| Revenue Growth | ★ 40.21 | N/A |
| 52 Week Low | $25.57 | $2.88 |
| 52 Week High | $40.72 | $24.00 |
Technical Indicators
Market Signals| Indicator | ORRF | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 35.78 | 48.61 |
| Support Level | $34.51 | $18.62 |
| Resistance Level | $35.28 | $21.50 |
| Average True Range (ATR) | 1.02 | 1.36 |
| MACD | -0.30 | -0.29 |
| Stochastic Oscillator | 10.12 | 21.35 |
Price Performance
Historical ComparisonAbout ORRF Orrstown Financial Services Inc
Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.